 Lindsey Wolf
Concepts (190)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herniorrhaphy | 6 | 2021 | 23 | 2.360 |
Why?
| | Hernia, Ventral | 3 | 2021 | 7 | 1.940 |
Why?
| | Health Services Accessibility | 4 | 2024 | 417 | 1.300 |
Why?
| | Accidents, Traffic | 3 | 2020 | 87 | 1.260 |
Why?
| | Hernia, Inguinal | 4 | 2021 | 18 | 1.190 |
Why?
| | Insurance Coverage | 5 | 2018 | 110 | 1.020 |
Why?
| | Appointments and Schedules | 1 | 2024 | 25 | 0.950 |
Why?
| | Child Mortality | 2 | 2020 | 11 | 0.760 |
Why?
| | Hernia, Femoral | 1 | 2021 | 1 | 0.750 |
Why?
| | Hernia, Umbilical | 1 | 2021 | 19 | 0.730 |
Why?
| | Watchful Waiting | 1 | 2019 | 27 | 0.650 |
Why?
| | Adolescent | 17 | 2024 | 6417 | 0.620 |
Why?
| | Child, Preschool | 12 | 2024 | 3879 | 0.580 |
Why?
| | Motor Vehicles | 1 | 2017 | 15 | 0.570 |
Why?
| | Child Restraint Systems | 1 | 2017 | 18 | 0.570 |
Why?
| | Infant | 11 | 2024 | 3575 | 0.560 |
Why?
| | Gastric Outlet Obstruction | 1 | 2016 | 7 | 0.550 |
Why?
| | Anti-HIV Agents | 5 | 2010 | 42 | 0.540 |
Why?
| | Pyloric Stenosis, Hypertrophic | 1 | 2016 | 21 | 0.540 |
Why?
| | Emergency Medical Services | 1 | 2017 | 110 | 0.530 |
Why?
| | Time-to-Treatment | 1 | 2017 | 70 | 0.530 |
Why?
| | HIV Infections | 6 | 2010 | 355 | 0.510 |
Why?
| | Child | 14 | 2024 | 6849 | 0.510 |
Why?
| | Male | 27 | 2024 | 25454 | 0.500 |
Why?
| | Hospital Mortality | 2 | 2018 | 409 | 0.490 |
Why?
| | Esophageal Neoplasms | 2 | 2016 | 104 | 0.490 |
Why?
| | Patient Selection | 1 | 2016 | 254 | 0.480 |
Why?
| | Female | 26 | 2024 | 26576 | 0.470 |
Why?
| | Laparoscopy | 3 | 2020 | 170 | 0.410 |
Why?
| | Esophageal and Gastric Varices | 1 | 2012 | 14 | 0.410 |
Why?
| | Endoscopy, Digestive System | 1 | 2012 | 51 | 0.400 |
Why?
| | Cost-Benefit Analysis | 6 | 2019 | 269 | 0.400 |
Why?
| | Quality Improvement | 3 | 2019 | 205 | 0.390 |
Why?
| | Pain, Postoperative | 2 | 2024 | 157 | 0.380 |
Why?
| | Retrospective Studies | 8 | 2024 | 6124 | 0.360 |
Why?
| | Appendicitis | 2 | 2024 | 62 | 0.350 |
Why?
| | Humans | 31 | 2024 | 49929 | 0.350 |
Why?
| | Databases, Factual | 5 | 2020 | 660 | 0.340 |
Why?
| | United States | 12 | 2020 | 4883 | 0.310 |
Why?
| | Trauma Centers | 2 | 2020 | 193 | 0.300 |
Why?
| | Referral and Consultation | 2 | 2024 | 285 | 0.290 |
Why?
| | Adult | 14 | 2019 | 13356 | 0.290 |
Why?
| | Analgesics, Opioid | 2 | 2024 | 554 | 0.280 |
Why?
| | Incidence | 6 | 2021 | 986 | 0.260 |
Why?
| | Povidone-Iodine | 1 | 2024 | 6 | 0.240 |
Why?
| | Peritoneal Lavage | 1 | 2024 | 5 | 0.240 |
Why?
| | Abdominal Abscess | 1 | 2024 | 13 | 0.240 |
Why?
| | Prevalence | 3 | 2021 | 956 | 0.240 |
Why?
| | Anti-Infective Agents, Local | 1 | 2024 | 27 | 0.240 |
Why?
| | Gastrostomy | 1 | 2024 | 55 | 0.230 |
Why?
| | Wounds and Injuries | 2 | 2018 | 281 | 0.230 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2024 | 51 | 0.230 |
Why?
| | Drug Prescriptions | 2 | 2024 | 95 | 0.230 |
Why?
| | Enteral Nutrition | 1 | 2024 | 148 | 0.230 |
Why?
| | Appendectomy | 2 | 2020 | 32 | 0.220 |
Why?
| | Logistic Models | 3 | 2016 | 896 | 0.220 |
Why?
| | Odds Ratio | 4 | 2020 | 548 | 0.220 |
Why?
| | Middle Aged | 11 | 2019 | 12293 | 0.220 |
Why?
| | Treatment Outcome | 4 | 2019 | 5178 | 0.220 |
Why?
| | Follow-Up Studies | 3 | 2018 | 2177 | 0.210 |
Why?
| | Hospitals, Pediatric | 1 | 2024 | 234 | 0.210 |
Why?
| | Guideline Adherence | 1 | 2024 | 134 | 0.210 |
Why?
| | Young Adult | 6 | 2019 | 4031 | 0.200 |
Why?
| | Rural Health Services | 1 | 2024 | 168 | 0.200 |
Why?
| | Rural Population | 2 | 2024 | 549 | 0.200 |
Why?
| | Cohort Studies | 4 | 2024 | 1403 | 0.200 |
Why?
| | Risk Factors | 5 | 2018 | 3605 | 0.190 |
Why?
| | Groin | 1 | 2021 | 16 | 0.190 |
Why?
| | Abdominal Wall | 1 | 2021 | 12 | 0.180 |
Why?
| | Infant, Newborn | 4 | 2021 | 2729 | 0.180 |
Why?
| | Aged | 5 | 2019 | 9449 | 0.170 |
Why?
| | Time Factors | 4 | 2024 | 2891 | 0.170 |
Why?
| | AIDS-Related Opportunistic Infections | 3 | 2009 | 40 | 0.170 |
Why?
| | Disease Models, Animal | 1 | 2024 | 1411 | 0.170 |
Why?
| | Confidence Intervals | 2 | 2016 | 155 | 0.170 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 51 | 0.170 |
Why?
| | Surgical Procedures, Operative | 1 | 2019 | 66 | 0.160 |
Why?
| | Aged, 80 and over | 3 | 2016 | 3138 | 0.160 |
Why?
| | Battered Child Syndrome | 1 | 2018 | 1 | 0.160 |
Why?
| | Splenic Diseases | 1 | 2018 | 6 | 0.160 |
Why?
| | Societies, Medical | 1 | 2019 | 177 | 0.160 |
Why?
| | Splenectomy | 1 | 2018 | 34 | 0.150 |
Why?
| | Testicular Diseases | 1 | 2018 | 4 | 0.150 |
Why?
| | Risk Assessment | 3 | 2016 | 1255 | 0.150 |
Why?
| | Quality of Health Care | 1 | 2018 | 184 | 0.140 |
Why?
| | Orthopedic Procedures | 1 | 2017 | 67 | 0.140 |
Why?
| | Pylorus | 1 | 2016 | 3 | 0.140 |
Why?
| | Malawi | 2 | 2016 | 10 | 0.140 |
Why?
| | Medically Uninsured | 1 | 2016 | 45 | 0.140 |
Why?
| | CD4 Lymphocyte Count | 4 | 2010 | 32 | 0.140 |
Why?
| | Age Factors | 2 | 2016 | 1092 | 0.130 |
Why?
| | Emergencies | 1 | 2016 | 84 | 0.130 |
Why?
| | Patient Admission | 1 | 2016 | 73 | 0.130 |
Why?
| | Postoperative Complications | 2 | 2024 | 1018 | 0.130 |
Why?
| | Patient Safety | 1 | 2016 | 102 | 0.130 |
Why?
| | Insurance, Health | 1 | 2016 | 131 | 0.130 |
Why?
| | Abdominal Pain | 1 | 2016 | 84 | 0.130 |
Why?
| | Sepsis | 1 | 2018 | 220 | 0.130 |
Why?
| | General Surgery | 1 | 2016 | 106 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2016 | 953 | 0.120 |
Why?
| | Computer Simulation | 4 | 2010 | 281 | 0.120 |
Why?
| | Transcriptome | 1 | 2016 | 312 | 0.120 |
Why?
| | Medicaid | 1 | 2016 | 255 | 0.120 |
Why?
| | Sex Factors | 1 | 2016 | 692 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 907 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2016 | 330 | 0.110 |
Why?
| | Healthcare Disparities | 1 | 2016 | 282 | 0.100 |
Why?
| | Hospitals, Public | 1 | 2012 | 7 | 0.100 |
Why?
| | Health Care Costs | 3 | 2009 | 168 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2012 | 579 | 0.090 |
Why?
| | Survival Analysis | 2 | 2007 | 670 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 157 | 0.080 |
Why?
| | Income | 2 | 2020 | 101 | 0.080 |
Why?
| | Caribbean Region | 1 | 2007 | 4 | 0.080 |
Why?
| | Cost of Illness | 1 | 2007 | 113 | 0.070 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2007 | 33 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 1576 | 0.070 |
Why?
| | Poisson Distribution | 2 | 2020 | 34 | 0.060 |
Why?
| | Patient Compliance | 1 | 2006 | 230 | 0.060 |
Why?
| | Intubation, Gastrointestinal | 1 | 2024 | 28 | 0.060 |
Why?
| | Emergency Service, Hospital | 2 | 2020 | 487 | 0.060 |
Why?
| | Tissue Adhesions | 1 | 2024 | 34 | 0.060 |
Why?
| | Tacrolimus | 1 | 2024 | 57 | 0.060 |
Why?
| | Postoperative Care | 1 | 2024 | 104 | 0.060 |
Why?
| | Mass Screening | 1 | 2007 | 346 | 0.060 |
Why?
| | Melanoma | 1 | 2007 | 281 | 0.050 |
Why?
| | Markov Chains | 2 | 2017 | 30 | 0.050 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 226 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 2 | 2017 | 63 | 0.050 |
Why?
| | Skin Neoplasms | 1 | 2007 | 487 | 0.050 |
Why?
| | Sensitivity and Specificity | 3 | 2009 | 858 | 0.050 |
Why?
| | Small-Area Analysis | 1 | 2020 | 7 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 458 | 0.050 |
Why?
| | Constipation | 1 | 2020 | 33 | 0.050 |
Why?
| | Local Government | 1 | 2020 | 23 | 0.050 |
Why?
| | Sex Distribution | 1 | 2020 | 135 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2020 | 105 | 0.040 |
Why?
| | Life Expectancy | 2 | 2010 | 33 | 0.040 |
Why?
| | Urban Population | 1 | 2020 | 151 | 0.040 |
Why?
| | Educational Status | 1 | 2020 | 224 | 0.040 |
Why?
| | Scoliosis | 1 | 2019 | 60 | 0.040 |
Why?
| | Spinal Fusion | 1 | 2019 | 69 | 0.040 |
Why?
| | United States Department of Defense | 1 | 2018 | 2 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2010 | 369 | 0.040 |
Why?
| | Cote d'Ivoire | 2 | 2010 | 2 | 0.040 |
Why?
| | Cleft Palate | 1 | 2019 | 75 | 0.040 |
Why?
| | Atrophy | 1 | 2018 | 38 | 0.040 |
Why?
| | Patient Readmission | 1 | 2019 | 222 | 0.040 |
Why?
| | Injury Severity Score | 1 | 2018 | 161 | 0.040 |
Why?
| | Anti-Infective Agents | 2 | 2009 | 95 | 0.040 |
Why?
| | Maryland | 1 | 2016 | 32 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2017 | 86 | 0.040 |
Why?
| | Role | 1 | 2016 | 6 | 0.030 |
Why?
| | Emergency Treatment | 1 | 2016 | 30 | 0.030 |
Why?
| | Gene Dosage | 1 | 2016 | 78 | 0.030 |
Why?
| | Length of Stay | 1 | 2019 | 624 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 658 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2016 | 176 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2016 | 174 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 127 | 0.030 |
Why?
| | Blood Pressure | 1 | 2018 | 519 | 0.030 |
Why?
| | Kidney | 1 | 2019 | 672 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 213 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2016 | 693 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 550 | 0.030 |
Why?
| | Mice | 1 | 2024 | 5658 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 584 | 0.030 |
Why?
| | Transcription Factors | 1 | 2016 | 565 | 0.030 |
Why?
| | Prognosis | 1 | 2018 | 1957 | 0.030 |
Why?
| | Mutation | 1 | 2016 | 1292 | 0.020 |
Why?
| | HIV-1 | 1 | 2010 | 53 | 0.020 |
Why?
| | Decision Trees | 1 | 2009 | 19 | 0.020 |
Why?
| | South Africa | 1 | 2009 | 22 | 0.020 |
Why?
| | Animals | 1 | 2024 | 13100 | 0.020 |
Why?
| | HIV Long-Term Survivors | 1 | 2007 | 1 | 0.020 |
Why?
| | Jamaica | 1 | 2007 | 8 | 0.020 |
Why?
| | Sentinel Surveillance | 1 | 2007 | 9 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2007 | 87 | 0.020 |
Why?
| | Boston | 1 | 2007 | 12 | 0.020 |
Why?
| | Toxoplasmosis | 1 | 2007 | 15 | 0.020 |
Why?
| | Morbidity | 1 | 2007 | 128 | 0.020 |
Why?
| | Siblings | 1 | 2007 | 33 | 0.020 |
Why?
| | Malaria | 1 | 2007 | 37 | 0.020 |
Why?
| | Disease Progression | 1 | 2009 | 820 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 404 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2007 | 94 | 0.020 |
Why?
| | Mycoses | 1 | 2007 | 158 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 380 | 0.020 |
Why?
| | Models, Statistical | 1 | 2006 | 225 | 0.020 |
Why?
| | Quality of Life | 1 | 2007 | 838 | 0.010 |
Why?
|
|
Wolf's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|